浙江华海药业股份有限公司 关于“华海转债”可选择回售的第八次提示性公告

Core Viewpoint - The company announces the right for holders of "Huahai Convertible Bonds" to sell back part or all of their unconverted bonds, with the buyback price set at RMB 100.30 per bond, including accrued interest and tax [1][4]. Group 1: Buyback Terms - Holders of "Huahai Convertible Bonds" can exercise their right to sell back the bonds if the company's stock price remains below 70% of the conversion price for 30 consecutive trading days during the last two interest years of the bond [2]. - The buyback price is calculated to include accrued interest, which for the sixth year at a coupon rate of 2.00% results in a total buyback price of RMB 100.30 per bond [5][10]. - The buyback period is set from December 22, 2025, to December 26, 2025, with funds to be disbursed on December 31, 2025 [4][11]. Group 2: Buyback Process - The buyback is not mandatory; bondholders have the option to choose whether to participate [6]. - Bondholders must submit their buyback requests through the Shanghai Stock Exchange trading system during the specified buyback period [7]. - If a buyback request is not successful on the first day, bondholders can continue to submit requests on subsequent days within the buyback period [8]. Group 3: Trading During Buyback Period - "Huahai Convertible Bonds" will continue to trade during the buyback period but will not allow conversion into shares [13]. - If the total face value of the bonds in circulation falls below RMB 30 million due to buybacks, trading will still continue until the end of the buyback period [13].

huahaipharm-浙江华海药业股份有限公司 关于“华海转债”可选择回售的第八次提示性公告 - Reportify